Pat PurcellMeeting Engagement
Matt TurnerPatient Affordability
Frank BurrellScientific Storytelling
Bud BilanichSuccess Coach
Matthew DurhamOmnidynamic Marketing
Paul TheisenPatient Acquisition
Stacey GandlerBrand Nourishment
Joey CohenMedication Adherence
David LinetskyPoint-of-Care Marketing
Daniel SontupeMarket Access
Liz KaneImpactful Strategy
Amy GilesIncreasing Engagement
Brenda SnowAuthentic Patient Voice
Suma Ramadas, PhDMedical Affairs
Investigational therapy crizanlizumab (SEG101, formerly SelG1) approximately doubled the time to first on-treatment sickle ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email